Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination

The renin–angiotensin–aldosterone system (RAAS), an important regulator of blood pressure and mediator of hypertension-related complications, is a prime target for cardiovascular drug therapy. Angiotensin-converting enzyme inhibitors (ACEIs) were the first drugs to be used to block the RAAS. Angiote...

Descripción completa

Detalles Bibliográficos
Autores principales: Cagnoni, Francesca, Njwe, Christian Achiri Ngu, Zaninelli, Augusto, Ricci, Alessandra Rossi, Daffra, Diletta, D’Ospina, Antonio, Preti, Paola, Destro, Maurizio
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922316/
https://www.ncbi.nlm.nih.gov/pubmed/20730071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922316/
https://www.ncbi.nlm.nih.gov/pubmed/20730071

Ejemplares similares